The combined companies will operate under the name Kalaris Therapeutics, Inc. and expects to report initial data from part 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback